# FDA Inspection 712920 - Baxalta Belgium Manufacturing SA - January 21, 2011

Source: https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/57ba0239-ccad-4fd3-bc2b-413d013423bb
Source feed: FDA_Inspections

> FDA Inspection 712920 for Baxalta Belgium Manufacturing SA on January 21, 2011. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 712920
- Company Name: Baxalta Belgium Manufacturing SA
- Inspection Date: 2011-01-21
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1251969 - 2024-11-22](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/115e13ec-e43f-4a5d-a6ea-a44fb33f7402)
- [FDA Inspection 1093550 - 2019-05-31](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/cd4ac129-b584-44b0-be5e-b240449bbf4c)
- [FDA Inspection 918229 - 2015-02-24](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/517a0fe7-a773-4b40-a359-fba5e341e1c6)
- [FDA Inspection 918229 - 2015-02-24](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/c3d349dd-96b7-4ba0-8825-6438659630b9)
- [FDA Inspection 841219 - 2013-06-18](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/1390dc0d-f01d-499b-ba27-14aca059294b)

Company: https://www.globalkeysolutions.net/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d